Neuraxis Inc
NRXS2.540USD
0.000
收盘 11/05, 16:00（美东）报价延迟15分钟
25.04M总市值
亏损市盈率 TTM
关于 Neuraxis Inc 公司
Neuraxis, Inc. 是一家专注于开发神经调节疗法以治疗儿童和成人慢性和衰弱性疾病的医疗技术公司。该公司致力于通过 IB-Stim 疗法推动科学发展，该疗法基于公司内部开发的经皮神经电场刺激 (PENFS) 技术。该公司的首款产品 IB-Stim 是一种 PENFS 系统，旨在用于 11-18 岁患有 IBS 相关功能性腹痛的患者。IB-Stim 旨在连续三周每周使用 120 小时，但不得超过四周，通过应用于脑神经 V、VII、IX 和 X 的分支以及通过透照识别的枕神经，与其他 IBS 疗法结合使用可帮助减轻疼痛。其正在研发的其他适应症包括儿童功能性恶心、儿童脑震荡后综合征和儿童周期性呕吐综合征。
Neuraxis Inc简介
公司代码NRXS
公司名称Neuraxis Inc
上市日期Aug 09, 2023
CEOMr. Brian Carrico
员工数量21
证券类型Ordinary Share
年结日Aug 09
公司地址11611 N. Meridian St
城市CARMEL
上市交易所NYSE American Consolidated
国家United States of America
邮编46032
电话18126890791
网址https://neuraxis.com/
公司代码NRXS
上市日期Aug 09, 2023
CEOMr. Brian Carrico
Neuraxis Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Christopher Robin (Chris) Brown
Dr. Christopher Robin (Chris) Brown
Director
Director
792.84K
--
Mr. Brian Carrico
Mr. Brian Carrico
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
20.12K
--
Ms. Kristin A. Ferge
Ms. Kristin A. Ferge
Independent Director
Independent Director
14.34K
--
Mr. Timothy R. Henrichs
Mr. Timothy R. Henrichs
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Thomas Carrico
Dr. Thomas Carrico
Chief Regulatory Officer, Compliance Officer and Privacy Officer
Chief Regulatory Officer, Compliance Officer and Privacy Officer
--
--
Ms. Beth Keyser
Ms. Beth Keyser
Independent Director
Independent Director
--
--
Mr. Gil Aharon
Mr. Gil Aharon
Independent Director
Independent Director
--
--
Dr. Adrian Miranda
Dr. Adrian Miranda
Chief Medical Officer, Senior Vice President - Science and Technology
Chief Medical Officer, Senior Vice President - Science and Technology
--
-100.00%
Mr. Bradley Mitch Watkins
Mr. Bradley Mitch Watkins
Independent Chairman of the Board
Independent Chairman of the Board
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Christopher Robin (Chris) Brown
Dr. Christopher Robin (Chris) Brown
Director
Director
792.84K
--
Mr. Brian Carrico
Mr. Brian Carrico
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
20.12K
--
Ms. Kristin A. Ferge
Ms. Kristin A. Ferge
Independent Director
Independent Director
14.34K
--
Mr. Timothy R. Henrichs
Mr. Timothy R. Henrichs
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Thomas Carrico
Dr. Thomas Carrico
Chief Regulatory Officer, Compliance Officer and Privacy Officer
Chief Regulatory Officer, Compliance Officer and Privacy Officer
--
--
Ms. Beth Keyser
Ms. Beth Keyser
Independent Director
Independent Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 10月15日 周三
更新时间: 10月15日 周三
持股股东
股东类型
持股股东
持股股东
占比
Hannasch (Brian)
11.33%
Brown (Christopher Robin)
7.94%
Bigger Capital Funds, LP
5.85%
AIGH Capital Management, LLC.
2.98%
Apis Capital Advisors LLC
1.24%
其他
70.66%
持股股东
持股股东
占比
Hannasch (Brian)
11.33%
Brown (Christopher Robin)
7.94%
Bigger Capital Funds, LP
5.85%
AIGH Capital Management, LLC.
2.98%
Apis Capital Advisors LLC
1.24%
其他
70.66%
股东类型
持股股东
占比
Individual Investor
20.16%
Hedge Fund
8.93%
Private Equity
2.98%
Investment Advisor
1.93%
Investment Advisor/Hedge Fund
1.53%
其他
64.47%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
28
1.53M
15.37%
+308.43K
2025Q2
29
2.67M
34.65%
-516.73K
2025Q1
31
4.67M
62.21%
+933.75K
2024Q4
29
4.04M
56.27%
+476.54K
2024Q3
28
3.89M
54.36%
+476.60K
2024Q2
27
3.62M
51.12%
+229.93K
2024Q1
18
1.89M
32.23%
+1.25M
2023Q4
18
2.14M
36.50%
+1.56M
2023Q3
14
2.07M
34.17%
+2.07M
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Hannasch (Brian)
1.13M
11.46%
+430.56K
+61.42%
Jul 01, 2025
Brown (Christopher Robin)
792.84K
8.03%
--
--
Mar 31, 2025
AIGH Capital Management, LLC.
297.44K
3.01%
+277.57K
+1397.01%
Jun 30, 2025
Apis Capital Advisors LLC
124.02K
1.26%
+124.02K
--
Jun 30, 2025
Parsons Capital Management, Inc.
116.73K
1.18%
--
--
Jun 30, 2025
Worth Venture Partners, LLC
102.56K
1.04%
+102.56K
--
Jun 30, 2025
Manatuck Hill Partners, LLC
50.42K
0.51%
+50.42K
--
Jun 30, 2025
The Vanguard Group, Inc.
27.98K
0.28%
--
--
Jun 30, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
